American Well CorpAMWL
Price$13.58Intrinsic value$17.2127% above price

Qualitative Analysis

Business overview

Business Overview

American Well Corporation (doing business as Amwell) is a leading enterprise software-as-a-service (SaaS) platform provider that digitally enables hybrid care delivery. The company's core offering, the Amwell Converge platform, serves as a comprehensive digital health infrastructure connecting payers, health systems, government entities, and clinical innovators. Rather than operating as a direct-to-consumer marketplace, Amwell provides the underlying technology layer—including software, Carepoint hardware devices, and clinical network services through the Amwell Medical Group (AMG)—to support virtual urgent care, chronic care management, virtual nursing, and acute specialty consults like telestroke and telepsychiatry.

Research as of 19 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Converge Platform MigrationTransformation

Migrating existing health plan and health system clients onto the unified Converge cloud-based platform to standardize the user experience, reduce maintenance costs, and eliminate expensive one-time customizations.

Expected impact: Improves gross margin stability, reduces customer churn, and increases average revenue per user (ARPU) through bundled software solutions.

Sign in / Sign up to read more
InvestmentOngoing R&D and client transition support, though overall R&D expenses are being disciplined.
TimelineMulti-year migration effort continuing through 2025 and 2026.
Operational Restructuring and Cost DisciplineEfficiency

Executing aggressive cost-reduction measures, including headcount reductions, abandoning corporate headquarters leases, and slashing sales, marketing, and R&D expenses to align the cost structure with a leaner revenue base.

Expected impact: Narrowed operating losses significantly (operating loss improved by 43% YoY in Q1 2026) and sets the stage for cash flow breakeven by Q4 2026.

Sign in / Sign up to read more
InvestmentRestructuring charges, including a $3.4 million impairment recorded in Q1 2026 for abandoning its corporate headquarters lease.
TimelineInitiated in 2024/2025 with ongoing quarterly expense reductions through 2026.
Focus on Government and Payer SegmentsGrowth

Shifting strategic focus away from the provider business toward high-value, sticky subscription revenue from government entities (such as the DHA) and large payer organizations.

Expected impact: Aims to increase the subscription revenue mix from 60% to 80% by 2027, creating a highly predictable and sticky revenue base.

Sign in / Sign up to read more
InvestmentTargeted go-to-market (GTM) spend on enterprise and government pipelines.
TimelineOngoing strategic pivot highlighted in early 2026 investor conferences.
Sources: 1

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Strategic Partnerships

LeidosGovernment Contract Consortium

Amwell operates as part of a Leidos-led partnership that was awarded an extension of its next-generation Digital First contract to power the digital transformation of the Military Health System (MHS), serving 9.6 million beneficiaries.

Terms: Financial terms of the extension were not fully disclosed, but the contract supports virtual care delivery across MHS providers, including expansions to the U.S. Coast Guard and U.S. MEPCOM.

Sign in / Sign up to read more
Elevance HealthCommercial Payer Agreement

A key three-year contract renewal that includes deploying the Converge platform, securing a major portion of Amwell's payer subscription revenue.

Terms: Three-year renewal term; specific financial figures are confidential.

Sign in / Sign up to read more
Sources: 1
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.